← Open Payments lookup

DOUGLAS BORGMAN: Open Payments

NPI 1306297122 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,848 in 197 payments from 17 companies in 2025. Trend: 2023 $2,292 · 2024 $5,110 · 2025 $4,848

Food & beverage: $4,848
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc21$751
Vanda Pharmaceuticals Inc.24$592
E.R. Squibb & Sons, L.L.C.22$578
ABBVIE INC.24$556
Neurocrine BioSciences, Inc.14$404
Otsuka America Pharmaceutical, Inc.14$367
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$279
Teva Pharmaceuticals USA, Inc.14$252
Axsome Therapeutics, Inc.8$219
Alkermes, Inc.7$189

Products named: FANAPT, SPRAVATO, COBENFY, VRAYLAR, INGREZZA, REXULTI, CAPLYTA, Auvelity.

Industry payments across CA — which companies pay providers there.